SEC Form D · filed August 28, 2015
Syndax Pharmaceuticals Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (24)
Luke Evnin, Ph.D · Waltham, MADirectorFabrice Egros, Ph.D · Waltham, MADirectorDennis Podlesak · Waltham, MADirectorHenry W. Chen · Waltham, MADirectorKim Kamdar, Ph.D · Waltham, MADirectorMichael W. Metzger · Waltham, MAExecJohn Pallies · Waltham, MAExecRichard P. Shea · Waltham, MADirectorRichard J. Berman · Boston, MAExecAlex Gleser · FORT WORTH, TXDirectorIvor Royston, M.D · Bozeman, MTDirectorGeorge W. Sledge, Jr., M.D · Waltham, MADirectorBriggs W. Morrison, M.D · Waltham, MAExec · DirectorRichard C. Temme · Woodland Hills, CADirectorRonald P. Kirkpatrick · Ponte Verde, FLExecRichard G. Chyette · Livonia, MIDirectorLowell G. Sears · San Carlos, CADirectorGisela G. Schwab · San Carlos, CADirectorAlbert Rabil, Iii · Boca Raton, FLDirectorH. Philip A. Goodeve · Boston, MADirectorDaniel H. Schneiderman · Boston, MAExecIvor Royston, M.D · Waltham, MADirectorGeorge W. Sledge, Jr., M.D · Waltham, MADirectorBriggs W. Morrison, M.D · Waltham, MAExec · Director Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗